Joseph Talcott
Obstetrics & Gynecology · Grand Rapids, MINPI 1134220270
Payments from drug & device makers
Across 204 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$847
- Novo Nordisk$717
- Astellas Pharma US Inc$438
- Daiichi Sankyo Inc.$262
- Lupin Inc.$156
- Exeltis, USA Inc.$140
- plus $758 from 22 others
What the payments were for
- Food & beverage$3,20297%
- Education$1153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $847 |
| Novo Nordisk | 56 | $717 |
| Astellas Pharma US Inc | 17 | $438 |
| Daiichi Sankyo Inc. | 9 | $262 |
| Lupin Inc. | 13 | $156 |
| Exeltis, USA Inc. | 8 | $140 |
| Lilly USA, LLC | 5 | $119 |
| Mayne Pharma Commercial LLC | 8 | $99 |
| Mylan Pharmaceuticals Inc. | 4 | $72 |
| Biogen | 2 | $51 |
| Pfizer | 3 | $45 |
| Aspira Women's Health Inc | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Therapeuticsmd, Inc. | 3 | $37 |
| Scynexis, Inc. | 1 | $25 |
| Myovant Sciences Inc. | 1 | $25 |
| Bayer | 2 | $24 |
| Sage Therapeutics, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
| Minerva Surgical, Inc | 1 | $16 |
| Merck | 1 | $16 |
| Exact Sciences | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Acessa Health Inc. | 1 | $14 |
| Organon | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$125
How this compares
$3,317 in reported general payments places this provider in the 85th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 11 | $10,966 |
| Estradiol | 44 | $2,690 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $119 | $10,96611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Other obstetrics & gynecology in Grand Rapids
- Gregory GresselGrand Rapids$157K
- Robyn HubbardGrand Rapids$73K
- Diana BitnerGrand Rapids$58K
- Stephen DalmGrand Rapids$48K
- Vivian Romero RomeroGrand Rapids$19K
- Haider MahdiDetroit$3.4M
- Andrew WagnerMidland$2M
- Jason BellAnn Arbor$548K
- Jacquelyn RobinsonSaginaw$539K
- Jouhaina MalehDearborn$524K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.